Related Experiment Videos
Molecular analysis of DQ beta 3.1 genes
1Virginia Mason Research Center, Seattle, WA 98101.
Human Immunology
|March 1, 1988
Summary
Human Leukocyte Antigen (HLA) DQ beta 3.1 genes, distinct from DQ beta 3.2, were sequenced. These findings suggest the DQ beta 3.1 allele arose through homologous recombination, impacting disease susceptibility.
Area of Science:
- Immunogenetics
- Molecular genetics
Background:
- Human Leukocyte Antigen (HLA) class II genes are linked to various disease susceptibilities.
- Previously identified DQw3 allelic variants show differential risk for Insulin-Dependent Diabetes Mellitus (IDDM).
Purpose of the Study:
- To compare DQ beta 3.1 genes associated with different haplotypes.
- To investigate the molecular basis of DQ beta 3.1 variation.
Main Methods:
- Sequencing of coding and noncoding regions of DQ beta genes from DR4-DQ beta 3.1 and DR8-DQ beta 3.1 haplotypes.
- Comparison of nucleotide and amino acid sequences between DQ beta 3.1 and DQ beta 3.2 alleles.
Main Results:
- DQ beta 3.1 genes from DR4 and DR8 haplotypes share nucleotide substitutions in coding and noncoding regions, distinguishing them from DQ beta 3.2.
- Six amino acid differences were identified between DQ beta 3.1 and DQ beta 3.2 alleles.
Conclusions:
- The DQ beta 3.1 allele exhibits distinct molecular characteristics compared to DQ beta 3.2.
- Homologous recombination is supported as a mechanism for the introduction of the DQ beta 3.1 allele onto diverse genetic backgrounds.